Quent Capital’s Alpha Tau Medical DRTS Stock Holding History

Quent Capital’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,000	Closed	-$99K	–	1560
2025 Q4	$99K	Buy	+20,000	New	+$84.3K	0.01%	562

Other funds holding DRTS

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $130M AUM

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Quent Capital's DRTS Position: Q1 2026 in Review

Quent Capital sold out of Alpha Tau Medical (DRTS) in Q1 2026, closing a stake of 20,000 shares — an estimated $99K sold.

Quent Capital first reported a position in DRTS in Q4 2025 and held it in 1 quarter. The position peaked at $99K in Q4 2025. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

Quent Capital reported no remaining Alpha Tau Medical position as of Q1 2026 after selling out during the quarter.
Quent Capital sold 20,000 Alpha Tau Medical shares in Q1 2026, an estimated $99K.
Quent Capital first reported a position in Alpha Tau Medical in Q4 2025 and held it in 1 quarter.
Quent Capital's Alpha Tau Medical position peaked at $99K in Q4 2025.
53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.